BioNTech SE (BNTX) Current Leases (2021 - 2024)
BioNTech SE's Current Leases history spans 4 years, with the latest figure at $42.2 million for Q4 2024.
- For Q4 2024, Current Leases rose 39.61% year-over-year to $42.2 million; the TTM value through Dec 2024 reached $42.2 million, up 39.61%, while the annual FY2024 figure was $42.8 million, 40.65% up from the prior year.
- Current Leases for Q4 2024 was $42.2 million at BioNTech SE, up from $30.2 million in the prior quarter.
- Across five years, Current Leases topped out at $42.2 million in Q4 2024 and bottomed at $30.2 million in Q4 2023.
- The 4-year median for Current Leases is $34.3 million (2021), against an average of $35.3 million.
- The largest annual shift saw Current Leases dropped 17.68% in 2023 before it skyrocketed 39.61% in 2024.
- A 4-year view of Current Leases shows it stood at $31.9 million in 2021, then increased by 15.08% to $36.7 million in 2022, then decreased by 17.68% to $30.2 million in 2023, then soared by 39.61% to $42.2 million in 2024.
- Per Business Quant, the three most recent readings for BNTX's Current Leases are $42.2 million (Q4 2024), $30.2 million (Q4 2023), and $36.7 million (Q4 2022).